Evidence map›Paper›PMID 42756959›Full record

ArticleCureus2026

Geographic Access to Urodynamics Studies in the United States: A Medicare-Based Geospatial Analysis.

Chetan Giduturi, Sofie Rosenberg, Tyler Muffly

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chetan GiduturiObstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, USA.
Sofie RosenbergObstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, USA.
Tyler MufflyDepartment of Obstetrics and Gynecology, Denver Health Medical Center, Denver, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to evaluate geographic access to traditional versus video urodynamics testing in the United States and Puerto Rico utilizing Medicare-billing data.

methodsWe performed a national geospatial analysis using the 2024 Medicare Physician and Other Practitioners Public Use File. Clinicians in urology and obstetrics and gynecology who billed Medicare Part B for urodynamics testing were identified using prespecified Healthcare Common Procedure Coding System (HCPCS) codes. Billing addresses from the mainland U.S. and Puerto Rico were cleaned, deduplicated, geocoded, and classified as centers offering traditional or video-associated urodynamics testing. State-level center density was calculated per million women using 2019-2023 American Community Survey population estimates. Centers were classified as metropolitan or nonmetropolitan using 2021 Census core-based statistical area boundaries. Census tract centroids were used as population origins, and distance to the nearest testing center was calculated and female population-weighted nationally and by state.  Results: Approximately 26.2 million women (15.7%) lived more than 100 miles from a video-associated urodynamics testing center, and 800,000 women (0.5%) lived more than 100 miles from a traditional urodynamics testing center. We identified 165 centers billing for video-associated urodynamics testing and 2,397 centers billing for traditional urodynamics testing in the United States and Puerto Rico. Testing centers were concentrated in the Northeast and Florida, with fewer centers across the Great Plains and Mountain West. Among 392 metropolitan areas, 310 (79%) lacked a video-associated urodynamics testing center, and 70 (17.9%) lacked a traditional urodynamics testing center. National median population-weighted distance was 27.8 miles for video-associated urodynamics testing and 3.6 miles for traditional urodynamics testing. The greatest access gaps differed by testing type but generally were observed in rural or low-density states.  Conclusions: Most women in the United States live within a short distance of a center billing for urodynamics testing, but meaningful geographic access gaps remain, particularly in rural regions, the Great Plains, and the Mountain West. These findings highlight the need for regional referral pathways, outreach models, and improved triage systems for patients with complex lower urinary tract symptoms (LUTS) who may require urodynamics evaluation.

Indexed as

advanced diagnostic testingclinical urodynamicsgeographic disparitygeospatial analysislower urinary tract symptoms (luts)medicare dataobstetrics and gyencologyurogynecology

Identifiers

PMID42756959
PMCPMC13584978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.